Advanced search
Publication Cover
Scandinavian Journal of Urology and Nephrology Volume 39, 2005 - Issue sup216
Submit an article Journal homepage
273
Views
167
CrossRef citations to date
0
Altmetric
Original Article

Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens

Jonathan I. Epstein Department of Pathology, The Johns Hopkins Hospital, Baltimore, Maryland, USACorrespondence[email protected]
,
Mahul Amin Departments of Pathology and Laboratory Medicine, Urology, Hematology and Oncology, Emory University School of Medicine, Atlanta, Georgia, USA
,
Liliane Boccon-Gibod Pathology Department, Faculté de Médecine Saint-Antoine, Hôpital Armand Trousseau, Paris, France
,
Lars Egevad Department of Pathology and Cytology, Karolinska University Hospital Solna, Stockholm, Sweden
,
Peter A. Humphrey Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA
,
Gregor Mikuz Department of Pathology, University of Innsbruck School of Medicine, Innsbruck, Austria
,
Don Newling Global Physician Urology, AstraZeneca, Macclesfield, UK
,
Sten Nilsson Department of Oncology, Karolinska University Hospital Solna, Stockholm, Sweden
,
Wael Sakr Department of Pathology, Wayne State University School of Medicine, Harper University Hospital, Detroit, Michigan, USA
,
John R. Srigley Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada
,
Thomas M. Wheeler Department of Pathology, Baylor College of Medicine, Houston, Texas, USA
&
Rodolfo Montironi Institute of Pathological Anatomy and Histopathology, School of Medicine, Polytechnic University of the Marche Region (Ancona), Ancona, Italy
 show all
Pages 34-63 | Published online: 09 Jul 2009

Citations (167)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (7)

Julia Adams & Liang Cheng. (2011) Lymph node-positive prostate cancer: current issues, emerging technology and impact on clinical outcome. Expert Review of Anticancer Therapy 11:9, pages 1457-1469.
Read now
Daniel M Berney, Rodolfo Montironi & Lars Egevad. (2011) Pathology in prostate research: Optimizing the pathological data. Acta Oncologica 50:sup1, pages 49-52.
Read now
Lars Egevad, Alexander Valdman, N. Peter Wiklund, Pascal Sève & Charles Dumontet. (2010) Beta-tubulin III expression in prostate cancer. Scandinavian Journal of Urology and Nephrology 44:6, pages 371-377.
Read now
George J. Netto & Jonathan I. Epstein. (2010) Theranostic and prognostic biomarkers: genomic applications in urological malignancies. Pathology 42:4, pages 384-394.
Read now
Brett Delahunt, John R. Srigley & David S. Lamb. (2009) Gleason grading: consensus and controversy. Pathology 41:7, pages 613-614.
Read now
Thorstein Sæther, Lars Tjugum Sørlien, Trond Viset, Stian Lydersen & Anders Angelsen. (2008) Are positive surgical margins in radical prostatectomy specimens an independent prognostic marker?. Scandinavian Journal of Urology and Nephrology 42:6, pages 514-521.
Read now
Matthias May, Michael Siegsmund, Fränze Hammermann, Volker Loy & Sven Gunia. (2007) Prognostic significance of proliferation activity and neuroendocrine differentiation to predict treatment failure after radical prostatectomy. Scandinavian Journal of Urology and Nephrology 41:5, pages 375-381.
Read now

Articles from other publishers (160)

Fangming Wang, Gang Zhang, Yuzhe Tang, Yunpeng Wang, Jianxing Li & Nianzeng Xing. (2023) Analysis of risk factors for positive surgical margin after laparoscopic radical prostatectomy with and without neoadjuvant hormonal therapy. Frontiers in Endocrinology 14.
Crossref
Johannes Kläger, Gabriel Wasinger, André Oszwald & Eva Compérat. (2023) The Prostate Is Not a Pill and Therefore Has No Capsule. Anatomia 2:3, pages 253-260.
Crossref
Rafał Osiecki, Mieszko Kozikowski, Beata Sarecka-Hujar, Michał Pyzlak & Jakub Dobruch. (2023) Prostate Cancer Morphologies: Cribriform Pattern and Intraductal Carcinoma Relations to Adverse Pathological and Clinical Outcomes—Systematic Review and Meta-Analysis. Cancers 15:5, pages 1372.
Crossref
Scott A. Greenberg, Hao G. Nguyen & Peter R. Carroll. 2022. Robotic Urologic Surgery. Robotic Urologic Surgery 373 384 .
Shuo Wang, Peng Du, Yudong Cao, Xiao Yang & Yong Yang. (2021) Tumor Biological Feature and Its Association with Positive Surgical Margins and Apical Margins after Radical Prostatectomy in Non-Metastasis Prostate Cancer. Current Oncology 28:2, pages 1528-1536.
Crossref
Jonathan I. Epstein, Mahul B. AminSamson W. FineFerran AlgabaManju AronDilek E. BaydarAntonio Lopez BeltranFadi BrimoJohn C. ChevilleMaurizio ColecchiaEva ComperatIsabela Werneck da CunhaWarick DelpradoAngelo M. DeMarzo, Giovanna A. GiannicoJennifer B. GordetskyCharles C. GuoDonna E. HanselMichelle S. HirschJiaoti HuangPeter A. HumphreyRafael E. JimenezFrancesca KhaniQingnuan Kong, Oleksandr N. KryvenkoL. Priya KunjuPriti LalMathieu LatourTamara Lotan, Fiona MacleanCristina Magi-GalluzziRohit MehraSantosh MenonHiroshi MiyamotoRodolfo MontironiGeorge J. NettoJane K. NguyenAdeboye O. OsunkoyaAnil ParwaniBrian D. RobinsonMark A. RubinRajal B. ShahJeffrey S. SoHiroyuki TakahashiFabio TavoraMaria S. TretiakovaLawrence TrueSara E. WobkerXiming J. YangMing ZhouDebra L. ZyngerKiril Trpkov. (2021) The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer. Archives of Pathology & Laboratory Medicine 145:4, pages 461-493.
Crossref
Min Lu, Shulin Wu & Chin-Lee Wu. (2021) Standardization of reporting discontinuous tumor involvement in prostatic needle biopsy: a systematic review. Virchows Archiv 478:3, pages 383-391.
Crossref
Farnoosh Nik‐Ahd, Lauren E Howard, William J Aronson, Martha K Terris, Zachary Klaassen, Matthew R Cooperberg, Christopher L Amling, Christopher J Kane & Stephen J Freedland. (2020) Obese men undergoing radical prostatectomy: Is robotic or retropubic better to limit positive surgical margins? Results from SEARCH. International Journal of Urology 27:10, pages 851-857.
Crossref
Lama Farchoukh, William A Laframboise, Joel B Nelson, Sheldon Bastacky, Anil V Parwani & Rajiv Dhir. (2020) Multifocal Extraprostatic Extension of Prostate Cancer. American Journal of Clinical Pathology 153:4, pages 548-553.
Crossref
Arnas Bakavičius, Mingailė Drevinskaitė, Kristina Daniūnaitė, Marija Barisienė, Sonata Jarmalaitė & Feliksas Jankevičius. (2020) The Impact of Prostate Cancer Upgrading and Upstaging on Biochemical Recurrence and Cancer-Specific Survival. Medicina 56:2, pages 61.
Crossref
David G. Bostwick & Liang Cheng. 2020. Urologic Surgical Pathology. Urologic Surgical Pathology 415 525.e42 .
Hyungwoo Ahn, Sung Il Hwang, Hak Jong Lee, Hyoung Sim Suh, Gheeyoung Choe, Seok-Soo Byun, Sung Kyu Hong, Sangchul Lee & Joongyub Lee. (2019) Prediction of extraprostatic extension on multi-parametric magnetic resonance imaging in patients with anterior prostate cancer. European Radiology 30:1, pages 26-37.
Crossref
Felix Preisser, Markus Graefen, Jens W. Köllermann, Thorsten Schlomm, Felix K. Chun & Hartwig Huland. 2020. Uroonkologie. Uroonkologie 1 18 .
Vebjørn Kvikstad, Ok Målfrid Mangrud, Einar Gudlaugsson, Ingvild Dalen, Hans Espeland, Jan P. A. Baak & Emiel A. M. Janssen. (2019) Prognostic value and reproducibility of different microscopic characteristics in the WHO grading systems for pTa and pT1 urinary bladder urothelial carcinomas. Diagnostic Pathology 14:1.
Crossref
Marko Klarić, Herman Haller, Alemka Brnčić Fischer, Emina Babarović, Aleksandra Prijić & Senija Eminović. (2019) The Role of CD44 and RHAMM in Endometrial (Endometrioid Type) Cancer: An Immunohistochemical Study. Applied Immunohistochemistry & Molecular Morphology 27:8, pages 606-612.
Crossref
James G. Kench, Meagan Judge, Brett Delahunt, Peter A. Humphrey, Glen Kristiansen, Jon Oxley, Krishan Rasiah, Hiroyuki Takahashi, Kiril Trpkov, Murali Varma, Thomas M. Wheeler, Ming Zhou, John R. Srigley & Lars Egevad. (2019) Dataset for the reporting of prostate carcinoma in radical prostatectomy specimens: updated recommendations from the International Collaboration on Cancer Reporting. Virchows Archiv 475:3, pages 263-277.
Crossref
Aram Kim, Myong Kim, Se Un Jeong, Cheryn Song, Yong Mee Cho, Jae Yoon Ro & Hanjong Ahn. (2018) Level of invasion into fibromuscular band is an independent factor for positive surgical margin and biochemical recurrence in men with organ confined prostate cancer. BMC Urology 18:1.
Crossref
Abdalla Deb. (2018) Significance of positive surgical margin and how to minimize in robotic radical prostatectomy. Urology & Nephrology Open Access Journal 6:4, pages 136-141.
Crossref
Jan Heidkamp, Martijn Hoogenboom, Iringo E. Kovacs, Andor Veltien, Arie Maat, J.P. Michiel Sedelaar, Christina A. Hulsbergen-van de Kaa & Jurgen J. Fütterer. (2018) Ex vivo MRI evaluation of prostate cancer: Localization and margin status prediction of prostate cancer in fresh radical prostatectomy specimens. Journal of Magnetic Resonance Imaging 47:2, pages 439-448.
Crossref
Maria Gkotzamanidou, Andreas C. Lazaris, Vasileios Spapis, Nikolaos Spetsieris & Popi Tsagaraki. 2018. Clinical Genitourinary Pathology. Clinical Genitourinary Pathology 267 395 .
Tarun Jindal, Firas Abdollah, Deepansh Dalela & Mani Menon. 2018. Robotics in Genitourinary Surgery. Robotics in Genitourinary Surgery 409 425 .
Darko Stefanovski, George Tang, Kolja Wawrowsky, Raymond C. Boston, Nils Lambrecht & Jian Tajbakhsh. (2017) Prostate cancer diagnosis using epigenetic biomarkers, 3D high-content imaging and probabilistic cell-by-cell classifiers. Oncotarget 8:34, pages 57278-57301.
Crossref
Mark K. Buyyounouski, Peter L. Choyke, Jesse K. McKenney, Oliver Sartor, Howard M. Sandler, Mahul B. Amin, Michael W. Kattan & Daniel W. Lin. (2017) Prostate cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA: A Cancer Journal for Clinicians 67:3, pages 245-253.
Crossref
Frank Friedersdorff, Britt Groß, Andreas Maxeiner, Klaus Jung, Kurt Miller, Carsten Stephan, Jonas Busch & Ergin Kilic. (2017) Does the Prostate Health Index Depend on Tumor Volume?—A Study on 196 Patients after Radical Prostatectomy. International Journal of Molecular Sciences 18:3, pages 488.
Crossref
Xiao Li, Yongsheng Pan, Yuan Huang, Jun Wang, Cheng Zhang, Jie Wu, Gong Cheng, Chao Qin, Lixin Hua & Zengjun Wang. (2016) Developing a model for forecasting Gleason score ≥7 in potential prostate cancer patients to reduce unnecessary prostate biopsies. International Urology and Nephrology 48:4, pages 535-540.
Crossref
Sung Yong ChoYoung Deuk Choi. (2016) The Effect of Tumor-Prostate Ratio on Biochemical Recurrence after Radical Prostatectomy. The World Journal of Men's Health 34:2, pages 123.
Crossref
Jun Wang, Gong Cheng, Xiao Li, Yuan Huang, Yongsheng Pan, Chao Qin, Lixin Hua & Zengjun Wang. (2016) Developing a Correct System to Evaluate the Accuracy of Gleason Score in Prostate Cancer of Chinese Population. Urologia Internationalis 96:3, pages 295-301.
Crossref
. 2016. Diagnostic Pathology: Genitourinary. Diagnostic Pathology: Genitourinary 538 543 .
Jeff M. Michalski, Thomas M. Pisansky, Colleen A.F. Lawton & Louis Potters. 2016. Clinical Radiation Oncology. Clinical Radiation Oncology 1038 1095.e18 .
Michael J. Whalen, Edan Y. Shapiro, Michael B. Rothberg, Andrew T. Turk, Solomon L. Woldu, Arindam Roy Choudhury, Trushar Patel & Ketan K. Badani. (2015) Close surgical margins after radical prostatectomy mimic biochemical recurrence rates of positive margins. Urologic Oncology: Seminars and Original Investigations 33:11, pages 494.e9-494.e14.
Crossref
Nevenka Miličević, Milanka Mrčela, Josip Galić & Ksenija Marjanović. (2015) Expression of proinflammatory cytokine interleukin-6 in tissue samples of human prostate obtained by needle biopsy. Pathology - Research and Practice 211:11, pages 865-870.
Crossref
Toshiaki Suzuki, Katsuhito Suwa, Masaichi Ogawa, Ken Eto, Hidejiro Kawahara, Tetsuji Fujita, Masahiro Ikegami & Katsuhiko Yanaga. (2015) Adjuvant chemotherapy for the perineural invasion of colorectal cancer. Journal of Surgical Research 199:1, pages 84-89.
Crossref
Ruta Gupta, Rachel O'Connell, Anne-Maree Haynes, Phillip D. Stricker, Wade Barrett, Jennifer J. Turner, Warick Delprado, Lisa G. Horvath & James G. Kench. (2015) Extraprostatic extension (EPE) of prostatic carcinoma: is its proximity to the surgical margin or Gleason score important?. BJU International 116:3, pages 343-350.
Crossref
Sung-Woo Park, Nathaniel Readal, Byong Chang Jeong, Elizabeth B. Humphreys, Jonathan I. Epstein, Alan W. Partin & Misop Han. (2015) Risk Factors for Intraprostatic Incision into Malignant Glands at Radical Prostatectomy. European Urology 68:2, pages 311-316.
Crossref
Craig R Ramsay, Temitope E Adewuyi, Joanne Gray, Jenni Hislop, Mark DF Shirley, Shalmini Jayakody, Graeme MacLennan, Cynthia Fraser, Sara MacLennan, Miriam Brazzelli, James N’Dow, Robert Pickard, Clare Robertson, Kieran Rothnie, Stephen P Rushton, Luke Vale & Thomas B Lam. (2015) Ablative therapy for people with localised prostate cancer: a systematic review and economic evaluation. Health Technology Assessment 19:49, pages 1-490.
Crossref
A. Karl, A. Buchner, C. Tympner, T. Kirchner, U. Ganswindt, C. Belka, R. Ganzer, M. Burger, F. Eder, F. Hofstädter, D. Schilling, K. Sievert, A. Stenzl, M. Scharpf, F. Fend, F. vom Dorp, H. Rübben, K. Schmid, D. Porres-Knoblauch, A. Heidenreich, B. Hangarter, R. Knüchel-Clarke, M. Rogenhofer, B. Wullich, A. Hartmann, E. Comploj, A. Pycha, E. Hanspeter, D. Pehrke, G. Sauter, M. Graefen, C. Stief & A. Haese. (2015) The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence. World Journal of Urology 33:7, pages 973-979.
Crossref
Richard J Bryant, Anne J Schmitt, Ian S D Roberts, Pelvender S Gill, Lisa Browning, Simon F Brewster, Freddie C Hamdy & Clare Verrill. (2015) Variation between specialist uropatholgists in reporting extraprostatic extension after radical prostatectomy. Journal of Clinical Pathology 68:6, pages 465-472.
Crossref
O.P. Oluwole, A.H. Rafindadi, M.S. Shehu & M.O.A. Samaila. (2015) A ten-year study of prostate cancer specimens at Ahmadu Bello University Teaching Hospital (A.B.U.T.H), Zaria, Nigeria. African Journal of Urology 21:1, pages 15-18.
Crossref
Cristina Magi-Galluzzi, Sara M. Falzarano & Christopher G. Przybycin. 2015. Genitourinary Pathology. Genitourinary Pathology 33 44 .
Zbigniew P. Kortylewicz, Elizabeth Mack, Charles A. Enke, Katherine A. Estes, R. Lee Mosley & Janina Baranowska-Kortylewicz. (2015) Preclinical evaluation of investigational radiopharmaceutical RISAD-P intended for use as a diagnostic and molecular radiotherapy agent for prostate cancer. The Prostate 75:1, pages 8-22.
Crossref
Alena Burdova, Jan Bouchal, Spiros Tavandzis & Zdenek Kolar. (2014) TMPRSS2-ERG gene fusion in prostate cancer. Biomedical Papers 158:4, pages 502-510.
Crossref
NOBUKI FURUBAYASHI, TAKAHITO NEGISHI, YU HIRATA, KENICHI TAGUCHI, MOTOTSUGU SHIMOKAWA & MOTONOBU NAKAMURA. (2014) Positive resection margins may not reflect the true margin in patients undergoing radical prostatectomy. Oncology Letters 8:5, pages 2237-2242.
Crossref
Shawn Christopher MaloneAnoop HaridassBalasz NyiriJennifer CrokeColin MaloneRodney H. BreauChristopher MorashLeonard AvruchManijeh DaneshmandKyle MaloneNicolas Roustan DelatourIleyaz AhmedEric Belanger. (2014) Creation of 3-Dimensional Prostate Cancer Maps: Methodology and Clinical and Research Implications. Archives of Pathology & Laboratory Medicine 138:6, pages 803-808.
Crossref
Dalsan You, In Gab Jeong, Cheryn Song, Yong Mee Cho, Jun Hyuk Hong, Choung-Soo Kim & Hanjong Ahn. (2014) High percent tumor volume predicts biochemical recurrence after radical prostatectomy in pathological stage T3a prostate cancer with a negative surgical margin. International Journal of Urology 21:5, pages 484-489.
Crossref
S. Adamis & I.M. Varkarakis. (2014) Defining prostate cancer risk after radical prostatectomy. European Journal of Surgical Oncology 40:5, pages 496-504.
Crossref
Alejandro Vélez Hoyos, José Jaime Correa, María Raquel Hessén, Carlos Humberto Martínez, Carlos Alberto Uribe, Camilo Pérez & Federico Escobar. (2014) Criterios diagnósticos en 400 biopsias de adenocarcinoma de próstata. Urología Colombiana 23:1, pages 35-38.
Crossref
Ju Hyun LimDalsan YouIn Gab JeongJun Hyuk HongHanjong AhnChoung-Soo Kim. (2014) Prognosis of Prostate Cancer With Other Primary Malignancies. Korean Journal of Urology 55:5, pages 327.
Crossref
Yoon Seok SuhHyeon Jun JangWan SongHye Won LeeHye Seung KimHwang Gyun JeonByong Chang JeongSeong Il SeoSeong Soo JeonHan Yong ChoiHyun Moo Lee. (2014) Location of Positive Surgical Margin and Its Association With Biochemical Recurrence Rate Do Not Differ Significantly in Four Different Types of Radical Prostatectomy. Korean Journal of Urology 55:12, pages 802.
Crossref
C. Börgermann, Felix K.-H. Chun, Patrick J. Bastian, K. Fischer, P. Fornara, M. Fröhner, M. Graefen, A. Haese, P. Hammerer, K. Heine, J. Heß, M.R. Hoda, H. Huland, J. Köllermann, H. Loertzer, H.-J. Luboldt, K. Miller, H. Rübben, T. Schlomm, M. Schostak, M. Schrader, R. Schwarz, I. Thederan, M. Wirth, J.M. Wolff & J. Hansen. 2014. Uroonkologie. Uroonkologie 513 676 .
Marcelo R. Noronha, Maisa M. Q. Quintal, Luis A. Magna, Leonardo O. Reis, Athanase Billis & Luciana R. Meirelles. (2013) Controversial predictors of biochemical recurrence after radical prostatectomy: a study from a Latin American (Brazilian) Institution. International braz j urol 39:6, pages 779-792.
Crossref
Jada Kapoor, Benjamin Namdarian, John Pedersen, Chris Hovens, Daniel Moon, Justin Peters, Anthony J. Costello, Paul Ruljancich & Niall M. Corcoran. (2013) Extraprostatic Extension into Periprostatic Fat is a More Important Determinant of Prostate Cancer Recurrence than an Invasive Phenotype. Journal of Urology 190:6, pages 2061-2067.
Crossref
Jesse D. Sammon, Quoc-Dien Trinh, Shyam Sukumar, Praful Ravi, Ariella Friedman, Maxine Sun, Jan Schmitges, Claudio Jeldres, Wooju Jeong, Navneet Mander, James O. Peabody, Pierre I. Karakiewicz & Michael Harris. (2013) Risk factors for biochemical recurrence following radical perineal prostatectomy in a large contemporary series: A detailed assessment of margin extent and location. Urologic Oncology: Seminars and Original Investigations 31:8, pages 1470-1476.
Crossref
Dirk Bottke, Reinhard Golz, Stephan Störkel, Axel Hinke, Alessandra Siegmann, Lothar Hertle, Kurt Miller, Wolfgang Hinkelbein & Thomas Wiegel. (2013) Phase 3 Study of Adjuvant Radiotherapy Versus Wait and See in pT3 Prostate Cancer: Impact of Pathology Review on Analysis. European Urology 64:2, pages 193-198.
Crossref
Daniela Danneman, Fredrik Wiklund, Nils Peter Wiklund & Lars Egevad. (2013) Prognostic significance of histopathological features of extraprostatic extension of prostate cancer. Histopathology, pages n/a-n/a.
Crossref
Eva Compérat, Philippe Camparo, John Srigley, Brett Delahunt, Lars Egevad, Mahul Amin, Daniel M. Berney, Athanase Billis, Liang Cheng, Jonathan Epstein, Andrew Evans, David Grignon, Peter Humphrey, Cristina Magi-Galuzzi, Rodolfo Montironi, Hemamali Samaratunga, Puay Hoon Tan, Lawrence True, Theo van der Kwast & Thomas Wheeler. (2013) Prise en charge de la pièce de prostatectomie radicale. Résultats de la conférence de consensus de la Société internationale d’uropathologie (ISUP). Annales de Pathologie 33:3, pages 155-161.
Crossref
George J. Netto. (2013) Clinical Applications of Recent Molecular Advances in Urologic Malignancies. Advances in Anatomic Pathology 20:3, pages 175-203.
Crossref
Knut Håkon Hole, Karol Axcrona, Agnes Kathrine Lie, Ljiljana Vlatkovic, Oliver Marcel Geier, Bjørn Brennhovd, Kjetil Knutstad, Dag Rune Olsen & Therese Seierstad. (2012) Routine pelvic MRI using phased-array coil for detection of extraprostatic tumour extension: accuracy and clinical significance. European Radiology 23:4, pages 1158-1166.
Crossref
Cheryn Song, Taejin Kang, Sangjun Yoo, In Gab Jeong, Jae Y. Ro, Jun Hyuk Hong, Choung-Soo Kim & Hanjong Ahn. (2013) Tumor volume, surgical margin, and the risk of biochemical recurrence in men with organ-confined prostate cancer. Urologic Oncology: Seminars and Original Investigations 31:2, pages 168-174.
Crossref
James G Kench, Brett Delahunt, David F Griffiths, Peter A Humphrey, Thomas McGowan, Kiril Trpkov, Murali Varma, Thomas M Wheeler & John R Srigley. (2012) Dataset for reporting of prostate carcinoma in radical prostatectomy specimens: recommendations from the International Collaboration on Cancer Reporting. Histopathology 62:2, pages 203-218.
Crossref
Massimo Mascolo, Daniela Russo & Gaetano De Rosa. 2013. Prostate Cancer: Shifting from Morphology to Biology. Prostate Cancer: Shifting from Morphology to Biology 3 42 .
Panagiotis J Vlachostergios, Foteini Karasavvidou, Grigorios Kakkas, Kassiani Kapatou, Ioannis Gioulbasanis, Danai D Daliani, George Moutzouris & Christos N Papandreou. (2012) Lack of prognostic significance of p16 and p27 after radical prostatectomy in hormone-naïve prostate cancer. Journal of Negative Results in BioMedicine 11:1.
Crossref
Yu-Jen Chen, Woei-Chyn Chu, Yeong-Shiau Pu, Shih-Chieh Chueh, Chia-Tung Shun & Wen-Yih Isaac Tseng. (2012) Washout gradient in dynamic contrast-enhanced MRI is associated with tumor aggressiveness of prostate cancer. Journal of Magnetic Resonance Imaging 36:4, pages 912-919.
Crossref
Adeboye O. Osunkoya. (2012) Update on prostate pathology. Pathology 44:5, pages 391-406.
Crossref
Adeboye O. Osunkoya & David J. Grignon. (2012) Practical issues and pitfalls in staging tumors of the genitourinary tract. Seminars in Diagnostic Pathology 29:3, pages 154-166.
Crossref
Jian Lu, Gregory J. Wirth, Shulin Wu, Junxing Chen, Douglas M. Dahl, Aria F. Olumi, Robert H. Young, W. Scott McDougal & Chin-Lee Wu. (2012) A Close Surgical Margin After Radical Prostatectomy is an Independent Predictor of Recurrence. Journal of Urology 188:1, pages 91-97.
Crossref
Samson W. Fine, Mahul B. Amin, Daniel M. Berney, Anders Bjartell, Lars Egevad, Jonathan I. Epstein, Peter A. Humphrey, Christina Magi-Galluzzi, Rodolfo Montironi & Christian Stief. (2012) A Contemporary Update on Pathology Reporting for Prostate Cancer: Biopsy and Radical Prostatectomy Specimens. European Urology 62:1, pages 20-39.
Crossref
G. Kristiansen, J.R. Srigley, B. Delahunt & L. Egevad. (2012) Diagnostik radikaler ProstatektomiepräparateDiagnostics of radical prostatectomy specimens. Der Pathologe 33:4, pages 337-344.
Crossref
George J. Netto & Liang Cheng. (2012) Emerging Critical Role of Molecular Testing in Diagnostic Genitourinary Pathology. Archives of Pathology & Laboratory Medicine 136:4, pages 372-390.
Crossref
Konrad Aumann, Dominic Amann, Vera Gumpp, Dieter Hauschke, Gian Kayser, Annette M May, Ulrich Wetterauer & Martin Werner. (2012) Template‐based synoptic reports improve the quality of pathology reports of prostatectomy specimens. Histopathology 60:4, pages 634-644.
Crossref
Ioannis A. Voutsadakis, Panagiotis J. Vlachostergios, Danai D. Daliani, Foteini Karasavvidou, Grigorios Kakkas, George Moutzouris, Michael D. Melekos & Christos N. Papandreou. (2012) CD10 Is Inversely Associated with Nuclear Factor-Kappa B and Predicts Biochemical Recurrence after Radical Prostatectomy. Urologia Internationalis 88:2, pages 158-164.
Crossref
Lars Egevad. (2011) Handling of radical prostatectomy specimens. Histopathology 60:1, pages 118-124.
Crossref
Alberto A. Antunes, Kátia R. Leite, Sabrina T. Reis, Juliana M. Sousa-Canavez, Luiz H. Camara-Lopes, Marcos F. Dall'Oglio & Miguel Srougi. (2012) GREB1 tissue expression is associated with organ-confined prostate cancer. Urologic Oncology: Seminars and Original Investigations 30:1, pages 16-20.
Crossref
Jeff M. Michalski, Thomas M. Pisansky, Colleen A. Lawton, Louis Potters & Deborah A. Kuban. 2012. Clinical Radiation Oncology. Clinical Radiation Oncology e51-1 e51-85 .
Sara M. Falzarano, Howard S. Levin & Cristina Magi-Galluzzi. 2013. Management of Prostate Cancer. Management of Prostate Cancer 153 176 .
S M Chan, F J Garcia, J L Chin, M Moussa & M Y Gabril. (2011) The clinical significance of in-depth pathological assessment of extraprostatic extension and margin status in radical prostatectomies for prostate cancer. Prostate Cancer and Prostatic Diseases 14:4, pages 307-312.
Crossref
Klaus Aumayr, Michael Breitegger, Peter R. Mazal, Anke Koller, Michael Marberger, Martin Susani & Andrea Haitel. (2011) Quantification of extraprostatic perineural spread and its prognostic value in pT3a pN0 M0 R0 prostate cancer patients. The Prostate 71:16, pages 1790-1795.
Crossref
Antoun Toubaji, Roula Albadine, Alan K Meeker, William B Isaacs, Tamara Lotan, Michael C Haffner, Alcides Chaux, Jonathan I Epstein, Misop Han, Patrick C Walsh, Alan W Partin, Angelo M De Marzo, Elizabeth A Platz & George J Netto. (2011) Increased gene copy number of ERG on chromosome 21 but not TMPRSS2–ERG fusion predicts outcome in prostatic adenocarcinomas. Modern Pathology 24:11, pages 1511-1520.
Crossref
Shahrokh F. Shariat, Thomas F. Chromecki, Julia Hoefer, Christopher E. Barbieri, Douglas S. Scherr, Pierre I. Karakiewicz, Claus G. Roehrborn, Francesco Montorsi, Zoran Culig & Ilaria T. Cavarretta. (2011) Soluble gp130 Regulates Prostate Cancer Invasion and Progression in an Interleukin-6 Dependent and Independent Manner. Journal of Urology 186:5, pages 2107-2114.
Crossref
Lars Egevad. (2011) Handling and reporting of radical prostatectomy specimens. Diagnostic Histopathology 17:10, pages 428-433.
Crossref
Andreas Josefsson, Hani Adamo, Peter Hammarsten, Torvald Granfors, Pär Stattin, Lars Egevad, Anna Engström Laurent, Pernilla Wikström & Anders Bergh. (2011) Prostate Cancer Increases Hyaluronan in Surrounding Nonmalignant Stroma, and This Response Is Associated with Tumor Growth and an Unfavorable Outcome. The American Journal of Pathology 179:4, pages 1961-1968.
Crossref
Xiaobing Fan, Chad R. Haney, Garima Agrawal, Charles A. Pelizzari, Tatjana Antic, Scott E. Eggener, Ila Sethi, Jonathan N. River, Marta Zamora, Gregory S. Karczmar & Aytekin Oto. (2011) High-resolution MRI of excised human prostate specimens acquired with 9.4T in detection and identification of cancers: Validation of a technique. Journal of Magnetic Resonance Imaging 34:4, pages 956-961.
Crossref
Marc Birkhahn, David F. Penson, Jie Cai, Susan Groshen, John P. Stein, Gary Lieskovsky, Donald G. Skinner & Richard J. Cote. (2011) Long‐term outcome in patients with a Gleason score ≤6 prostate cancer treated by radical prostatectomy. BJU International 108:5, pages 660-664.
Crossref
Seong Cheol Kim, Cheryn Song, Wansuk Kim, Taejin Kang, Jinsung Park, In Gab Jeong, Sangmi Lee, Yong Mee Cho & Hanjong Ahn. (2011) Factors Determining Functional Outcomes After Radical Prostatectomy: Robot-Assisted Versus Retropubic. European Urology 60:3, pages 413-419.
Crossref
James G. Kench, David R. Clouston, Warick Delprado, Thomas Eade, David Ellis, Lisa G. Horvath, Hemamali Samaratunga, Jurgen Stahl, Alan M.F. Stapleton, Lars Egevad, John R. Srigley & Brett Delahunt. (2011) Prognostic factors in prostate cancer. Key elements in structured histopathology reporting of radical prostatectomy specimens. Pathology 43:5, pages 410-419.
Crossref
Guillaume Ploussard, Mohammad Ali Agamy, Olivier Alenda, Yves Allory, Pascal Mouracade, Dimitri Vordos, Andras Hoznek, Claude-Clément Abbou, Alexandre de la Taille & Laurent Salomon. (2011) Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients. BJU International 107:11, pages 1748-1754.
Crossref
Matthew R. Smith, Anthony L. Zietman, Joel S. Finkelstein & Chin-Lee Wu. (2011) Case 16-2011. New England Journal of Medicine 364:21, pages 2044-2051.
Crossref
George J. Netto. (2011) Molecular Diagnostics in Urologic Malignancies: A Work in Progress. Archives of Pathology & Laboratory Medicine 135:5, pages 610-621.
Crossref
Young Hwii Ko, Deuk Jae Sung, Sung Gu Kang, Seok Ho Kang, Jeong Gu Lee, Je Jong Kim & Jun Cheon. (2011) The predictability of T3 disease in staging MRI following prostate biopsy decreases in patients with high initial PSA and Gleason score. Asian Journal of Andrology 13:3, pages 487-493.
Crossref
George J. Netto, Mario Eisenberger & Jonathan I. Epstein. (2011) Interobserver Variability in Histologic Evaluation of Radical Prostatectomy Between Central and Local Pathologists: Findings of TAX 3501 Multinational Clinical Trial. Urology 77:5, pages 1155-1160.
Crossref
Matthew D. Truesdale, Philippa J. Cheetham, Andrew T. Turk, Samantha Sartori, Gregory W. Hruby, Eion P. Dinneen, Mitchell C. Benson & Ketan K. Badani. (2011) Gleason score concordance on biopsy-confirmed prostate cancer: is pathological re-evaluation necessary prior to radical prostatectomy?. BJU International 107:5, pages 749-754.
Crossref
Hemamali Samaratunga, Rodolfo Montironi, Lawrence True, Jonathan I Epstein, David F Griffiths, Peter A Humphrey, Theo van der Kwast, Thomas M Wheeler, John R Srigley, Brett Delahunt & Lars Egevad. (2011) International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 1: specimen handling. Modern Pathology 24:1, pages 6-15.
Crossref
Daniel M Berney, Thomas M Wheeler, David J Grignon, Jonathan I Epstein, David F Griffiths, Peter A Humphrey, Theo van der Kwast, Rodolfo Montironi, Brett Delahunt, Lars Egevad & John R Srigley. (2011) International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 4: seminal vesicles and lymph nodes. Modern Pathology 24:1, pages 39-47.
Crossref
Cristina Magi-Galluzzi, Andrew J Evans, Brett Delahunt, Jonathan I Epstein, David F Griffiths, Theo H van der Kwast, Rodolfo Montironi, Thomas M Wheeler, John R Srigley, Lars L Egevad & Peter A Humphrey. (2011) International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 3: extraprostatic extension, lymphovascular invasion and locally advanced disease. Modern Pathology 24:1, pages 26-38.
Crossref
Puay Hoon Tan, Liang Cheng, John R Srigley, David Griffiths, Peter A Humphrey, Theodore H van der Kwast, Rodolfo Montironi, Thomas M Wheeler, Brett Delahunt, Lars Egevad & Jonathan I Epstein. (2011) International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 5: surgical margins. Modern Pathology 24:1, pages 48-57.
Crossref
George J. Netto & Jonathan I. Epstein. 2011. Diagnostic Immunohistochemistry. Diagnostic Immunohistochemistry 593 661 .
Jeff M. Michalski & Thomas Wiegel. 2012. Technical Basis of Radiation Therapy. Technical Basis of Radiation Therapy 949 1025 .
Okyaz Eminaga, Reemt Hinkelammert, Axel Semjonow, Joerg Neumann, Mahmoud Abbas, Thomas Koepke, Olaf Bettendorf, Elke Eltze & Martin Dugas. (2010) Clinical map document based on XML (cMDX): document architecture with mapping feature for reporting and analysing prostate cancer in radical prostatectomy specimens. BMC Medical Informatics and Decision Making 10:1.
Crossref
Simon R.J. Bott, Hashim U. Ahmed, Richard G. Hindley, Ahmad Abdul‐Rahman, Alex Freeman & Mark Emberton. (2010) The index lesion and focal therapy: an analysis of the pathological characteristics of prostate cancer. BJU International 106:11, pages 1607-1611.
Crossref
R. Jeffrey Karnes, John C. Cheville, Cristiane M. Ida, Thomas J. Sebo, Asha A. Nair, Hui Tang, Jan-Marie Munz, Farhad Kosari & George Vasmatzis. (2010) The Ability of Biomarkers to Predict Systemic Progression in Men with High-Risk Prostate Cancer Treated Surgically Is Dependent on ERG Status . Cancer Research 70:22, pages 8994-9002.
Crossref
Samson W Fine, Anuradha Gopalan, Margaret A Leversha, Hikmat A Al-Ahmadie, Satish K Tickoo, Qin Zhou, Jaya M Satagopan, Peter T Scardino, William L Gerald & Victor E Reuter. (2010) TMPRSS2–ERG gene fusion is associated with low Gleason scores and not with high-grade morphological features. Modern Pathology 23:10, pages 1325-1333.
Crossref
Shady Salem, Sam S. Chang, Peter E. Clark, Rodney Davis, S. Duke Herrell, Yakup Kordan, Marcia L. Wills, Scott B. Shappell, Roxelyn Baumgartner, Sharon Phillips, Joseph A. Smith, Michael S. Cookson & Daniel A. Barocas. (2010) Comparative Analysis of Whole Mount Processing and Systematic Sampling of Radical Prostatectomy Specimens: Pathological Outcomes and Risk of Biochemical Recurrence. Journal of Urology 184:4, pages 1334-1340.
Crossref
Lars Budäus, Hendrik Isbarn, Christian Eichelberg, Giovanni Lughezzani, Maxine Sun, Paul Perrotte, Felix K.H. Chun, Georg Salomon, Thomas Steuber, Jens Köllermann, Guido Sauter, Sascha A. Ahyai, Mario Zacharias, Margit Fisch, Thorsten Schlomm, Alexander Haese, Hans Heinzer, Hartwig Huland, Francesco Montorsi, Markus Graefen & Pierre I. Karakiewicz. (2010) Biochemical Recurrence After Radical Prostatectomy: Multiplicative Interaction Between Surgical Margin Status and Pathological Stage. Journal of Urology 184:4, pages 1341-1346.
Crossref
Sara M. Falzarano & Cristina Magi-Galluzzi. (2010) Staging prostate cancer and its relationship to prognosis. Diagnostic Histopathology 16:9, pages 432-438.
Crossref
Aaron M. Harvey, Beverly Grice, Candice Hamilton, Luan D. Truong, Jae Y. Ro, Alberto G. Ayala & Qihui “Jim” Zhai. (2010) Diagnostic Utility of P504S/p63 Cocktail, Prostate-Specific Antigen, and Prostatic Acid Phosphatase in Verifying Prostatic Carcinoma Involvement in Seminal Vesicles: A Study of 57 Cases of Radical Prostatectomy Specimens of Pathologic Stage pT3b. Archives of Pathology & Laboratory Medicine 134:7, pages 983-988.
Crossref
Alfonso Gómez-Iturriaga Piña, Juanita Mary Crook, Paul Kwan, Jette Borg & Clement Ma. (2010) The impact of perineural invasion on biochemical outcome after permanent prostate iodine-125 brachytherapy. Brachytherapy 9:3, pages 213-218.
Crossref
Louis R. Bégin & Tarek A. Bismar. 2010. Male Reproductive Cancers. Male Reproductive Cancers 87 120 .
Catherine LiebigGustavo AyalaJonathan WilksGordana VerstovsekHao LiuNeeti AgarwalDavid H. BergerDaniel Albo. (2009) Perineural Invasion Is an Independent Predictor of Outcome in Colorectal Cancer. Journal of Clinical Oncology 27:31, pages 5131-5137.
Crossref
Roula Albadine, Mathieu Latour, Antoun Toubaji, Michael Haffner, William B Isaacs, Elizabeth A Platz, Alan K Meeker, Angelo M Demarzo, Jonathan I Epstein & George J Netto. (2009) TMPRSS2–ERG gene fusion status in minute (minimal) prostatic adenocarcinoma. Modern Pathology 22:11, pages 1415-1422.
Crossref
John R. Srigley, Peter A. Humphrey, Mahul B. Amin, Sam S. Chang, Lars Egevad, Jonathan I. Epstein, David J. Grignon, James M. McKiernan, Rodolfo Montironi, Andrew A. Renshaw, Victor E. Reuter & Thomas M. Wheeler. (2009) Protocol for the Examination of Specimens From Patients With Carcinoma of the Prostate Gland. Archives of Pathology & Laboratory Medicine 133:10, pages 1568-1576.
Crossref
Athanase Billis. (2009) A pathological reassessment of organ-confined, Gleason score 6 prostatic adenocarcinomas that progress after radical prostatectomy. International braz j urol 35:5, pages 620-621.
Crossref
Kyungeun KimPil June PakJae Y. RoDongik ShinSoo-Jin HuhYong Mee Cho. (2009) Limited Sampling of Radical Prostatectomy Specimens With Excellent Preservation of Prognostic Parameters of Prostate Cancer. Archives of Pathology & Laboratory Medicine 133:8, pages 1278-1284.
Crossref
Hwang Gyun Jeon, Jungbum Bae, Jun-Seok Yi, In Sik Hwang, Sang Eun Lee & Eunsik Lee. (2009) Perineural invasion is a prognostic factor for biochemical failure after radical prostatectomy. International Journal of Urology 16:8, pages 682-686.
Crossref
Achim Fleischmann, Sylviane Schobinger, Martin Schumacher, George N. Thalmann & Urs E. Studer. (2008) Survival in surgically treated, nodal positive prostate cancer patients is predicted by histopathological characteristics of the primary tumor and its lymph node metastases. The Prostate 69:4, pages 352-362.
Crossref
Gary W. Bong, Chad W.M. Ritenour, Adeboye O. Osunkoya, M. Timothy Smith & Thomas E. Keane. (2009) Evaluation of modern pathological criteria for positive margins in radical prostatectomy specimens and their use for predicting biochemical recurrence. BJU International 103:3, pages 327-331.
Crossref
Rodolfo Montironi, Liang Cheng, Roberta Mazzucchelli & Antonio Lopez‐Beltran. (2009) PATHOLOGICAL DEFINITION AND DIFFICULTIES IN ASSESSING POSITIVE MARGINS IN RADICAL PROSTATECTOMY SPECIMENS. BJU International 103:3, pages 286-288.
Crossref
Alberto A. Antunes, Kátia R. Leite, Juliana M. Sousa-Canavez, Luiz H. Camara-Lopes & Miguel Srougi. (2009) The Role of Prostate Specific Membrane Antigen and Pepsinogen C Tissue Expression as an Adjunctive Method to Prostate Cancer Diagnosis. Journal of Urology 181:2, pages 594-600.
Crossref
Ryo Ishida, Hiroaki Kobayashi, Shinri Yoshida, Masahiro Ogawa, Takako Shiota, Toshinori Nishikimi, Hiroshi Yamada & Keisuke Yokoi. (2009) CLINICAL STUDY OF RADICAL PROSTATECTOMY FOR PROSTATE CANCER FROM SINGLE INSTITUTION. The Japanese Journal of Urology 100:6, pages 615-624.
Crossref
Ofer Yossepowitch, Anders Bjartell, James A. Eastham, Markus Graefen, Bertrand D. Guillonneau, Pierre I. Karakiewicz, Rodolfo Montironi & Franceso Montorsi. (2009) Positive Surgical Margins in Radical Prostatectomy: Outlining the Problem and Its Long-Term Consequences. European Urology 55:1, pages 87-99.
Crossref
Christof Börgermann, Felix K. -H. Chun, Paolo Fornara, Michael Fröhner, Markus Graefen, Alexander Haese, Peter Hammerer, Karsten Heine, Hartwig Huland, J. Köllermann, Hagen Loertzer, Hans-Joachim Luboldt, Kurt Miller, Herbert Rübben, Thorsten Schlomm, Martin Schostak, Mark Schrader, Rudolf Schwarz, Axel Semjonow, Sigried Wagner, Manfred Wirth & Johannes M. Wolff. 2009. Uroonkologie. Uroonkologie 485 635 .
Inge M. van Oort, Christina A. Hulsbergen-vandeKaa & J. Alfred Witjes. (2008) Prognostic Factors in Radical Prostatectomy Specimens: What Do We Need to Know from Pathologists?. European Urology Supplements 7:12, pages 715-722.
Crossref
Andrew J. Evans, Pauline C. Henry, Theodorus H. Van der Kwast, Douglas C. Tkachuk, Kemp Watson, Gina A. Lockwood, Neil E. Fleshner, Carol Cheung, Eric C. Belanger, Mahul B. Amin, Liliane Boccon-Gibod, David G. Bostwick, Lars Egevad, Jonathan I. Epstein, David J. Grignon, Edward C. Jones, Rodolfo Montironi, Madeleine Moussa, Joan M. Sweet, Kiril Trpkov, Thomas M. Wheeler & John R. Srigley. (2008) Interobserver Variability Between Expert Urologic Pathologists for Extraprostatic Extension and Surgical Margin Status in Radical Prostatectomy Specimens. American Journal of Surgical Pathology 32:10, pages 1503-1512.
Crossref
L Egevad, F Algaba, D M Berney, L Boccon-Gibod, D F Griffiths, A Lopez-Beltran, G Mikuz, M Varma & R Montironi. (2008) Handling and reporting of radical prostatectomy specimens in Europe: a web-based survey by the European Network of Uropathology (ENUP). Histopathology 53:3, pages 333-339.
Crossref
John C. Cheville, R. Jeffrey Karnes, Terry M. Therneau, Farhad Kosari, Jan-Marie Munz, Lori Tillmans, Eati Basal, Laureano J. Rangel, Eric Bergstralh, Irina V. Kovtun, C.D. Savci-Heijink, Eric W. Klee & George Vasmatzis. (2008) Gene Panel Model Predictive of Outcome in Men at High-Risk of Systemic Progression and Death From Prostate Cancer After Radical Retropubic Prostatectomy. Journal of Clinical Oncology 26:24, pages 3930-3936.
Crossref
Athanase Billis. (2008) Pathology. International braz j urol 34:4, pages 525-527.
Crossref
Ivana Regina Gonçalves, Carlos Padovani & Regina Célia Popim. (2008) Caracterização epidemiológica e demográfica de homens com câncer de próstata. Ciência & Saúde Coletiva 13:4, pages 1337-1342.
Crossref
Ai-Ying Chuang & Jonathan I. Epstein. (2008) Positive Surgical Margins in Areas of Capsular Incision in Otherwise Organ-confined Disease at Radical Prostatectomy: Histologic Features and Pitfalls. American Journal of Surgical Pathology 32:8, pages 1201-1206.
Crossref
Maddi Garmendia, Ayman Gaafar, Carmen Etxezarraga, Aitziber Ugalde & José I. López. (2008) Parámetros histológicos predictivos de la invasión de las vesículas seminales en el cáncer de próstata. Revista Española de Patología 41:3, pages 183-188.
Crossref
Katia R. Leite, Miguel Srougi, Marcos F. Dall'Oglio, Adriana Sanudo & Luiz H. Camara-Lopes. (2008) Histopathological findings in extended prostate biopsy with PSA ≤ 4 ng/mL. International braz j urol 34:3, pages 283-292.
Crossref
Ole Johan Halvorsen. (2008) Molecular and prognostic markers in prostate cancer. APMIS 116, pages 1-62.
Crossref
Sven Gunia, Knut Albrecht, Stefan Koch, Thomas Herrmann, Thorsten Ecke, Volker Loy, Jörg Linke, Michael Siegsmund & Matthias May. (2008) Ki67 staining index and neuroendocrine differentiation aggravate adverse prognostic parameters in prostate cancer and are characterized by negligible inter-observer variability. World Journal of Urology 26:3, pages 243-250.
Crossref
Christopher Alan Maxwell, James McCarthy & Eva Turley. (2008) Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions?. Journal of Cell Science 121:7, pages 925-932.
Crossref
Farhad Kosari, Jan Marie A. Munz, C. Dilara Savci-Heijink, Craig Spiro, Eric W. Klee, Dagmar Marie Kube, Lori Tillmans, Jeff Slezak, R. Jeffrey Karnes, John C. Cheville & George Vasmatzis. (2008) Identification of Prognostic Biomarkers for Prostate Cancer. Clinical Cancer Research 14:6, pages 1734-1743.
Crossref
Theodorus H. van der Kwast, Laurence Collette & Michel Bolla. (2008) In Reply:. Journal of Clinical Oncology 26:8, pages 1392-1393.
Crossref
Athanase Billis, Isabela C. Watanabe, Matheus V. Costa, Gilliat H. Telles & Luis A. Magna. (2007) Iatrogenic and non-iatrogenic positive margins: incidence, site, factors involved, and time to PSA progression following radical prostatectomy. International Urology and Nephrology 40:1, pages 105-111.
Crossref
Marbele S. Guimaraes, Maisa M. Quintal, Luciana R. Meirelles, Luis A. Magna, Ubirajara Ferreira & Athanase Billis. (2008) Gleason score as predictor of clinicopathologic findings and biochemical (PSA) progression following radical prostatectomy. International braz j urol 34:1, pages 23-29.
Crossref
Rodolfo Montironi. (2008) Re: Radial Distance of Extraprostatic Extension Measured by Ocular Micrometer is an Independent Predictor of Prostate-Specific Antigen Recurrence. A New Proposal for the Substaging of pT3a Prostate Cancer. European Urology 53:2, pages 449-450.
Crossref
Ferran Algaba. (2008) Pitfalls of Pathologic Staging in Prostate Cancer. European Urology Supplements 7:1, pages 6-14.
Crossref
. (2008) Recommendations for the Reporting of Prostate Carcinoma. American Journal of Clinical Pathology 129:1, pages 24-30.
Crossref
David G. Bostwick & Isabelle Meiers. 2008. Urologic Surgical Pathology. Urologic Surgical Pathology 442 579 .
Ming-Tse Sung, Darrell D. Davidson, Rodolfo Montironi, Antonio Lopez-Beltran & Liang Cheng. (2007) Radical prostatectomy specimen processing: A critical appraisal of sampling methods. Current Diagnostic Pathology 13:6, pages 490-498.
Crossref
Athanase Billis, Daniel A. Teixeira, Rafael F. Stelini, Maísa M. Quintal, Marbele S. Guimarães & Ubirajara Ferreira. (2007) Seminal vesicle invasion in radical prostatectomies: Which is the most common route of invasion?. International Urology and Nephrology 39:4, pages 1097-1102.
Crossref
Ai-Ying Chuang, Matthew E. Nielsen, David J. Hernandez, Patrick C. Walsh & Jonathan I. Epstein. (2007) The Significance of Positive Surgical Margin in Areas of Capsular Incision in Otherwise Organ Confined Disease at Radical Prostatectomy. Journal of Urology 178:4, pages 1306-1310.
Crossref
Jan Adolfsson, Bernhard Tribukait & Seymour Levitt. (2007) The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic Value of Tumour Ploidy and Comorbidity. European Urology 52:4, pages 1028-1035.
Crossref
V. Moliniè & A. Descazeaud. (2007) Apport de l'anatomie patholosique avant et après prostatectomie totale. Annales d'Urologie 41, pages S51-S58.
Crossref
Theodorus H. Van der KwastMichel BollaHein Van PoppelPaul Van CanghKris VekemansLuigi Da PozzoJean-Francois BossetKarl H. KurthFritz H. SchröderLaurence Collette. (2007) Identification of Patients With Prostate Cancer Who Benefit From Immediate Postoperative Radiotherapy: EORTC 22911. Journal of Clinical Oncology 25:27, pages 4178-4186.
Crossref
Megan M. Merrill, Brian R. Lane, Alwyn M. Reuther, Ming Zhou, Cristina Magi-Galluzzi & Eric A. Klein. (2007) Tumor Volume Does Not Predict for Biochemical Recurrence After Radical Prostatectomy in Patients with Surgical Gleason Score 6 or Less Prostate Cancer. Urology 70:2, pages 294-298.
Crossref
Ai-Ying Chuang, Shu-Jen Chang, Cheng-Fang Horng & Mei-Hua Tsou. (2007) Study of Prostate Cancer Pathologic Features in Chinese Populations. Urology 69:5, pages 915-920.
Crossref
Matthias May, Olaf Kaufmann, Fränze Hammermann, Volker Loy & Michael Siegsmund. (2007) Prognostic impact of lymphovascular invasion in radical prostatectomy specimens. BJU International 99:3, pages 539-544.
Crossref
M May, M Siegsmund, F Hammermann, V Loy & S Gunia. (2006) Visual estimation of the tumor volume in prostate cancer: a useful means for predicting biochemical-free survival after radical prostatectomy?. Prostate Cancer and Prostatic Diseases 10:1, pages 66-71.
Crossref
Ming-Tse Sung, Haiqun Lin, Michael O. Koch, Darrell D. Davidson & Liang Cheng. (2007) Radial Distance of Extraprostatic Extension Measured by Ocular Micrometer is an Independent Predictor of Prostate-specific Antigen Recurrence. The American Journal of Surgical Pathology 31:2, pages 311-318.
Crossref
F. Algaba, Y. Arce, J.Mª. Santaularia & H. Villavicencio Mavrich. (2007) La biopsia intraoperatoria en patología oncológica urológica. Actas Urológicas Españolas 31:9, pages 945-956.
Crossref
Theodorus H. van der Kwast, Laurence Collette, Hein Van Poppel, Paul Van Cangh, Kris Vekemans, Luigi DaPozzo, Jean-François Bosset, Karl H. Kurth, Fritz H. Schröder & Michel Bolla. (2006) Impact of pathology review of stage and margin status of radical prostatectomy specimens (EORTC trial 22911). Virchows Archiv 449:4, pages 428-434.
Crossref
Helena Lexander, Carina Palmberg, Ulf Hellman, Gert Auer, Magnus Hellström, Bo Franzén, Hans Jörnvall & Lars Egevad. (2006) Correlation of protein expression, Gleason score and DNA ploidy in prostate cancer. PROTEOMICS 6:15, pages 4370-4380.
Crossref
John R. Srigley, Mahul B. Amin, Jonathan I. Epstein, David J. Grignon, Peter A. Humphrey, Andrew A. Renshaw & Thomas M. Wheeler. (2006) Updated Protocol for the Examination of Specimens From Patients With Carcinomas of the Prostate Gland. Archives of Pathology & Laboratory Medicine 130:7, pages 936-946.
Crossref
Anders Bjartell. (2006) The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. European Urology 49:4, pages 758-759.
Crossref
Fritz H. Schröder, Claartje Gosselaar, Stijn Roemeling, Renske Postma, Monique J. Roobol & Chris H. Bangma. (2006) PSA and the Detection of Prostate Cancer After 2005. Part II: Ways Out of the PSA Dilemma?. EAU-EBU Update Series 4:2, pages 71-81.
Crossref
John R. Srigley. (2006) Key Issues in Handling and Reporting Radical Prostatectomy Specimens. Archives of Pathology & Laboratory Medicine 130:3, pages 303-317.
Crossref
RODOLFO MONTIRONI, ROBERTA MAZZUCCHELLI, MARINA SCARPELLI, ANTONIO LOPEZ-BELTRAN & GREGOR MIKUZ. (2006) Prostate carcinoma I: prognostic factors in radical prostatectomy specimens and pelvic lymph nodes. BJU International 97:3, pages 485-491.
Crossref
Antonio Lopez-Beltran, Gregor Mikuz, Rafael J. Luque, Roberta Mazzucchelli & Rodolfo Montironi. (2005) Current practice of Gleason grading of prostate carcinoma. Virchows Archiv 448:2, pages 111-118.
Crossref
Jonathan I Epstein, William C Allsbrook, Mahul B Amin & Lars L Egevad. (2005) The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. American Journal of Surgical Pathology 29:9, pages 1228-1242.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.